F11R and breast carcinoma: The F11R/JAM-A antagonistic peptide P4D has altered the morphology of the endothelial (EA.hy926, HMEC-1) and breast cancer (MDA-MB-231) cell lines grown for 7 days in monolayers (Fig. 2).